Navigation Links
Neurocrine Biosciences To Present At The Bank of America Merrill Lynch 2013 Health Care Conference
Date:5/9/2013

SAN DIEGO, May 9, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman , President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas.  

The live presentation takes place on Thursday, May 16 at 11:20 a.m. Pacific Time / 2:20 p.m. Eastern Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600 or ir@neurocrine.com.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for one month.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

 


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neurocrine Biosciences Reports Fourth Quarter And Year End 2012 Results
2. Neurocrine Biosciences To Present At The 24th Annual Piper Jaffray Healthcare Conference
3. Neurocrine Biosciences Reports Third Quarter 2012 Results
4. Neurocrine Biosciences Reports Second Quarter 2012 Results
5. Neurocrine Biosciences to Present at The 24th Annual Roth Conference
6. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
7. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
8. Provitro Biosciences Awarded First-Ever U.S. Patent For Large-Scale Production Of Bamboo Plants
9. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
10. Quanta BioSciences qRT-PCR technology recommended in newly published CDC protocol for detection of H7N9 Avian Influenza
11. Centrillion Biosciences Announces Next-Gen Sequencing Innovation Grant Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... ... 2017 , ... Tunnell Consulting has been solving the most complex ... challenges faced by life sciences, biotech and pharmaceuticals companies today is in interpreting the ... , who is well known in the industry and brings significant high-level expertise to ...
(Date:6/16/2017)... , ... June 16, 2017 , ... CTNext , ... Innovation Awards (EIA), held at The LOFT at Chelsea Piers in Stamford. , Nine ... to a panel of judges for an opportunity to secure $10,000 awards to help ...
(Date:6/15/2017)... ... 15, 2017 , ... angelMD announced the closure of a ... angelMD’s SVP of Corporate Development, served as the syndicate leader for this first ... Saranas’ recently announced $4 million Series B financing round. , Saranas is working ...
(Date:6/14/2017)... ... June 14, 2017 , ... The Thailand Board ... announces that they’re co-hosting a delegation from Thailand at BIO 2017 in San ... industry gathering in the world, regroups more than 1,100 biotech companies, academic institutions, ...
Breaking Biology Technology:
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
Breaking Biology News(10 mins):